Epidemiological aspects of melanoma at a university hospital dermatology center over a period of 20 years;Aspectos epidemiológicos do melanoma em serviço de dermatologia de hospital universitário em um período de 20 anos

Anais Brasileiros de Dermatologia

Volumn 88, Issue 3, 2013, Pages 344-353

  Brandão, Flavia Vieira ^a   Pereira, Ana Francisca Junqueira Ribeiro ^b   Gontijo, Bernardo ^b   Bittencourt, Flávia Vasques ^b  

^a HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Epidemiology; Lentigo; Melanoma

Indexed keywords

ADULT; ARTICLE; BLEEDING; CANCER LOCALIZATION; CAUCASIAN; DEATH; DERMATOLOGY; DYSPLASTIC NEVUS; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; TUMOR INVASION; UNIVERSITY HOSPITAL; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BRAZIL; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITALS, TEACHING; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; INCIDENCE; INFANT; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS; SKIN PIGMENTATION; TIME FACTORS; YOUNG ADULT;

EID: 84879587449     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20131855     Document Type: Article

References (50)

1. Markovic SN, Erickson LA, Rao RD, Weoenig RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st sentury, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82:364-80.
2. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27:3-9.
3. Liang JJ, Robinson E, Martin RC. Cutaneous melanoma in New Zealand: 2000-2004. ANZ J Surg. 2010;80:312-6.
4. Altekruse S F, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al, editors. SEER Cancer Statistics Review, 1975-2007 (Vintage 2009 Populations), National Cancer Institute. [cited 2010 mar 13]. Available from: http://seer.cancer.gov/csr/1975_2007/.
5. Inca.gov [Internet]. Estimativa 2010: Incidência de Câncer no Brasil [acesso 20 nov 2010]. Disponível em: http://www.inca.gov.br/estimativa/2010/index.asp?link=con-teudo_view.asp&ID=5
6. Desmierre M F, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol. 2005;141:745-50.
7. Geller AC, Swetter SM, Brooks K, Demierre M F, Yaroch AL. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol. 2007;57:555-72.
8. Berwick M, Erdei E, Hay J. Melanoma epidemiology and public health. Dermatol Clin. 2009;27:205-14.
9. Belfort FA, Waisntein AJA. Etiopatogenia - Melanócito ao Melanoma. In: Belfort FA, Waisntein AJA, editores. Melanoma: diagnóstico e tratamento. São Paulo: Lemar; 2010. p. 37-45.
10. Paek SC, Sober AJ, Tsao HT, Mihm Jr MC, Johnson TM. Cutaneous melanoma. In: Wolf K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's Dermatology in general medicine. New York: Mc Graw Hill; 2008. p.1134-57
11. Lucas EA, Deps PD, Lima JGB, Toriblo R, Gomes CC. Malignant melanoma: retrospective study in the period 1982-1992, in the University Hospital of UFES. Arq Bras Med. 1994;68:67-70.
12. Bakos L, Wagner M, Bakos R, Leite CSM, Sperhacke CL, Dzekaniak KS, et al. Sunburn, sunscreen, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol. 2002; 41:557-62.
13. Gon AS, Minelli L, Guembarovski AL. Primary cutaneous melanoma in Londrina. An Bras Dermatol. 2001;76:413-26.
14. Borges SZ, Bakos L, Cartell A, Wagner M, Agostini A, Lersch E. Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil. Int J Dermatol. 2007; 46:679-86.
15. Dimatos DC, Duarte FO, Machado RS, Vieira VJ, Vasconcelos ZAA, Bins-Ely J et al. Melanoma cutâneo no Brasil. Arq Cat Med. 2009;38:S14-19
16. Ferrari Júnior NM, Muller H, Ribeiro M, Maia M, Sanches Júnior JA. Cutaneous melanoma: descriptive epidemiological study. Sao Paulo Med J. 2008; 126:41-7.
17. Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front Biosci 2006; 11:1244-54.
18. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer.1998;83:1664-78.
19. Cabrera R, Silva S, Días de Medina J, Hoell I, Gugliemetti A, Rohmann I. Clinical study of 113 cases of malignant melanoma. Rev Med Chil. 1994;122:900-6.
20. Buettner PG, Leiter U, Eigentler TK, Garbe C. Development of prognostic factors and survival in cutaneous melanoma over 25 Years. An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer. 2005;103:616-24.
21. Fernandes NC, Cardoso ICL, Maceira J, Perez M. Melanoma: estudo retrospectivo de 47 casos. An Bras Dermatol. 1996;71:381-85.
22. Fernandes NC, Calmon R, Maceira J P, Cuzzi T, Silva CSC. Cutaneous melanoma: prospective study of 65 cases. An Bras Dermatol. 2005;80:25-34.
23. Loria D, Matos E. Risk factors for cutaneous melanoma: a case-control study in Argentina. Int J Dermatol. 2001;40:108-14.
24. Nagore E, Oliver V, Botella-Estrada R, Moreno-Picot S, Guillén C, Fortea JM. Clinicopathological analysis of 1571 cutaneous malignant melanoma in Valencia, Spain: factors related to tumour thickness. Acta Derm Venerol. 2006;86:50-6.
25. Lindholm C, Anderson R, Dufmats M, Hansson J, Ingvar C, Möller T, et al. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer. 2004;101:2067-78.
26. Garbe C, MMleod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer. 2000;89:1269-78.
27. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: analysis of California Cancer Registry data, 1988-93. Cancer Causes Control. 1997;8:246-52.
28. Forman SB, Ferringer TC, Peckham SJ, Dalton SR, Sasaki GT, Libow LF, et al. Is superficial spreading melanoma still the most common form of malignant melanoma. J Am Acad Dermatol. 2008;58:1013-20.
29. Bakos L Melanomas malignos e etnia. An Bras Dermatol. 1991;66:299-302.
30. Ponzio HA, Bernadi CDV, Favaretto AL, Brancher MM. Rate of malignant melanoma in Service of Dermatology of ISCMPA/UFRGS. An Bras Dermatol. 1998;73:S8.
31. Moreno M. Perfil dos pacientes com melanoma no oeste de Santa Catarina, Brasil. Grupo Brasileiro de Melanoma. Boletim informativo do GBM. 2005;3:3. [Acesso 13 mar 2010] Disponível em: http://www.gbm.org.br/gbm/boletim/2005/infor31.aspx.
32. Battisti R, Nunes DH, Weber A, Schweitzer LC, Sgrott I. Evaluation of the epidemiological profile and the mortality rate of the patients with primary cutaneous melanoma in Florianopolis - SC, Brazil. An Bras Dermatol. 2009; 84:335-42.
33. Nasser N. Epidemiologia do melanoma maligno em Blumenau-SC. An Bras Dermatol. 1993;68:17-20.
34. Minelli L, Pereira VL Melanoma - Estudo casuístico do Instituto de Câncer de Londrina. An Bras Dermatol. 1983;58:81-4.
35. Lebsa-Weber A, Nunes DH, Filho JJS, Pinto CJC. Assessment of 496 pathological reports of melanoma diagnosed in the city of Florianopolis, SC, Brazil An Bras Dermatol. 2007;82:227-32.
36. Gandini S, Sera F, Cattaruzza MS, Pasquini P Abeni D, Boyle P et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41:28-44.
37. Ferrone CR, Ben Porat L, Panageas KS, Berwick M, Halpern AC, Patel A, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294:1647-54.
38. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancers. J Photochem Photobiol B. 2001;63:8-18.
39. Wolff J, Wollina U. Second malignancies in melanoma patients in Thuringia. J Eur Acad Dermatol Venereol. 2000;14:479-83.
40. van der Velden HM, van Hossum NM, Blokx WA, Boezeman JB. Gerritsen MJ. Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients. Dermatol Res Pract. 2009. doi: 10.1155/2009/479183
41. Jen M, Murphy M, Grant-Kels J. Childhood melanoma. Clin Dermatol. 2009;27:529-36.
42. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final Version of 2009 AJCC Melanoma Staging and Classification. J Clin Oncol. 2009;27:6199-206.
43. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol. 2007;57:555-72.
44. Castro LGM, Toyama CL, Gomes AP Freire MA, Brito TF. Câncer de pele em clínica particular em São Paulo - SP. An Bras Dermatol. 1996;71:471-6.
45. Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol. 2005;53:393-406.
46. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-34.
47. Negin BP, Riedel E, Oliveria SA, Berwick M, Coit DG, Brady MS. Symptoms and signs of primary melanoma. Important indicators of Breslow Depth. Cancer. 2003;98:344-8.
48. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004;150:179-85.
49. Hedge U.P.,Chakraborty N, Kerr P Grant-Kels JM. Melanoma in the elderly patient: relevance of the aging immune system. Clin Dermatol. 2009;27:537-44.
50. Downard CD, Rapkin LB, Gow KW. Melanoma in children and adolescents. Surg